LYEL
Lyell Immunopharma, Inc. (LYEL)
NASDAQ · Healthcare
Lyell Immunopharma, Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lyell Immunopharma, Inc. revenue for the quarter ending March 31, 2026 was 2000, a 71.43% decrease year-over-year.
- Lyell Immunopharma, Inc. revenue for the twelve months ending March 31, 2026 was 32000, a 57.33% decrease year-over-year.
- Lyell Immunopharma, Inc. annual revenue for 2025 was 36000, a 40.98% decrease from 2024.
- Lyell Immunopharma, Inc. annual revenue for 2024 was 61000, a 53.08% decrease from 2023.
- Lyell Immunopharma, Inc. annual revenue for 2023 was 130000, a 99.85% decrease from 2022.
- Lyell Immunopharma, Inc. annual revenue for 2022 was 84.7 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lyell Immunopharma, Inc. Market Cap — FAQ
Lyell Immunopharma, Inc. (LYEL) market cap over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LYEL's market cap history?
The chart and table above show Lyell Immunopharma, Inc.'s market cap by year and by quarter, including the growth rate.